The moral dilemma of the polio eradication programme
Author(s) -
Thomas John,
Dhanya Dharmapalan
Publication year - 2019
Publication title -
indian journal of medical ethics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.204
H-Index - 16
eISSN - 0975-5691
pISSN - 0974-8466
DOI - 10.20529/ijme.2019.060
Subject(s) - poliomyelitis , poliomyelitis eradication , polio vaccination , dilemma , polio vaccine , public health , global health , developing country , outbreak , virology , economic growth , medicine , political science , poliovirus , socioeconomics , environmental health , virus , economics , nursing , philosophy , epistemology
During the last five years, globally, cases of polio caused by vaccine viruses have outnumbered those of polio caused by natural (wild) polioviruses, posing a moral dilemma. Public health ethics should ensure the best interests of the community, with equity in sharing benefits and risks irrespective of socioeconomic disparities. Vaccine viruses in oral polio vaccine (OPV) cause vaccine-associated paralytic polio (VAPP), while paralytic polio is also caused by vaccine-derived polioviruses (VDPVs). By its policy of the use of OPV in low and middle-income countries, while rich countries use the safe inactivated polio vaccine (IPV), the Global Polio Eradication Programme has been responsible for social injustice. In 2017 and 2018, there were outbreaks of polio in Syria and Papua New Guinea due to circulating VDPVs, after many years of these countries remaining free of polio due to wild polioviruses. The only ethical way forward for global polio eradication is to replace OPV with IPV in all countries.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom